AllianceBernstein’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $739K | Hold |
36,840
| – | – | ﹤0.01% | 2447 |
|
|
2025
Q1 | $725K | Hold |
36,840
| – | – | ﹤0.01% | 2389 |
|
|
2024
Q4 | $829K | Hold |
36,840
| – | – | ﹤0.01% | 2418 |
|
|
2024
Q3 | $941K | Hold |
36,840
| – | – | ﹤0.01% | 2357 |
|
|
2024
Q2 | $861K | Buy |
36,840
+20,850
| +130% | +$487K | ﹤0.01% | 2387 |
|
|
2024
Q1 | $281K | Buy |
15,990
+1,020
| +7% | +$17.9K | ﹤0.01% | 2819 |
|
|
2023
Q4 | $207K | Buy |
14,970
+640
| +4% | +$8.86K | ﹤0.01% | 2974 |
|
|
2023
Q3 | $196K | Buy |
+14,330
| New | +$196K | ﹤0.01% | 2964 |
|